nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—breast cancer—Estradiol—osteoporosis	0.215	0.363	CpDpCtD
Aprepitant—breast cancer—Conjugated Estrogens—osteoporosis	0.215	0.363	CpDpCtD
Aprepitant—breast cancer—Ethinyl Estradiol—osteoporosis	0.163	0.275	CpDpCtD
Aprepitant—CYP1A2—Estropipate—osteoporosis	0.0262	0.104	CbGbCtD
Aprepitant—CYP2C9—Estropipate—osteoporosis	0.0236	0.0941	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0195	0.0777	CbGbCtD
Aprepitant—CYP3A7—Estradiol—osteoporosis	0.0195	0.0777	CbGbCtD
Aprepitant—CYP2C19—Cholecalciferol—osteoporosis	0.0146	0.0583	CbGbCtD
Aprepitant—CYP3A5—Estradiol—osteoporosis	0.0146	0.0583	CbGbCtD
Aprepitant—CYP3A4—Estropipate—osteoporosis	0.0137	0.0547	CbGbCtD
Aprepitant—CYP3A4—Calcitriol—osteoporosis	0.0137	0.0547	CbGbCtD
Aprepitant—CYP1A2—Conjugated Estrogens—osteoporosis	0.0124	0.0494	CbGbCtD
Aprepitant—CYP2C9—Cholecalciferol—osteoporosis	0.0122	0.0485	CbGbCtD
Aprepitant—CYP2C19—Estradiol—osteoporosis	0.0118	0.047	CbGbCtD
Aprepitant—CYP3A4—Ergocalciferol—osteoporosis	0.011	0.0438	CbGbCtD
Aprepitant—CYP1A2—Estradiol—osteoporosis	0.0109	0.0434	CbGbCtD
Aprepitant—CYP2C9—Estradiol—osteoporosis	0.0098	0.0391	CbGbCtD
Aprepitant—CYP3A4—Raloxifene—osteoporosis	0.00915	0.0365	CbGbCtD
Aprepitant—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00884	0.0353	CbGbCtD
Aprepitant—CYP3A4—Cholecalciferol—osteoporosis	0.00707	0.0282	CbGbCtD
Aprepitant—CYP3A4—Conjugated Estrogens—osteoporosis	0.00649	0.0259	CbGbCtD
Aprepitant—CYP3A4—Estradiol—osteoporosis	0.0057	0.0227	CbGbCtD
Aprepitant—Convulsion—Conjugated Estrogens—osteoporosis	8.39e-05	0.000629	CcSEcCtD
Aprepitant—Dry mouth—Zoledronate—osteoporosis	8.38e-05	0.000628	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	8.37e-05	0.000628	CcSEcCtD
Aprepitant—Fatigue—Ethinyl Estradiol—osteoporosis	8.36e-05	0.000627	CcSEcCtD
Aprepitant—Pruritus—Alendronate—osteoporosis	8.34e-05	0.000625	CcSEcCtD
Aprepitant—Dyspepsia—Risedronate—osteoporosis	8.33e-05	0.000624	CcSEcCtD
Aprepitant—Eye disorder—Estradiol—osteoporosis	8.32e-05	0.000624	CcSEcCtD
Aprepitant—Tinnitus—Estradiol—osteoporosis	8.31e-05	0.000623	CcSEcCtD
Aprepitant—Constipation—Ethinyl Estradiol—osteoporosis	8.3e-05	0.000622	CcSEcCtD
Aprepitant—Confusional state—Zoledronate—osteoporosis	8.28e-05	0.000621	CcSEcCtD
Aprepitant—Hypersensitivity—Calcitriol—osteoporosis	8.28e-05	0.000621	CcSEcCtD
Aprepitant—Cardiac disorder—Estradiol—osteoporosis	8.27e-05	0.00062	CcSEcCtD
Aprepitant—Flushing—Estradiol—osteoporosis	8.27e-05	0.00062	CcSEcCtD
Aprepitant—Chest pain—Conjugated Estrogens—osteoporosis	8.25e-05	0.000618	CcSEcCtD
Aprepitant—Arthralgia—Conjugated Estrogens—osteoporosis	8.25e-05	0.000618	CcSEcCtD
Aprepitant—Myalgia—Conjugated Estrogens—osteoporosis	8.25e-05	0.000618	CcSEcCtD
Aprepitant—Asthenia—Ibandronate—osteoporosis	8.23e-05	0.000617	CcSEcCtD
Aprepitant—Anxiety—Conjugated Estrogens—osteoporosis	8.22e-05	0.000616	CcSEcCtD
Aprepitant—Nausea—Etidronic acid—osteoporosis	8.22e-05	0.000616	CcSEcCtD
Aprepitant—Oedema—Zoledronate—osteoporosis	8.21e-05	0.000616	CcSEcCtD
Aprepitant—Anaphylactic shock—Zoledronate—osteoporosis	8.21e-05	0.000616	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	8.19e-05	0.000614	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Pamidronate—osteoporosis	8.19e-05	0.000614	CcSEcCtD
Aprepitant—Diarrhoea—Estropipate—osteoporosis	8.19e-05	0.000614	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Risedronate—osteoporosis	8.17e-05	0.000612	CcSEcCtD
Aprepitant—Infection—Zoledronate—osteoporosis	8.16e-05	0.000612	CcSEcCtD
Aprepitant—Fatigue—Risedronate—osteoporosis	8.15e-05	0.000611	CcSEcCtD
Aprepitant—Insomnia—Pamidronate—osteoporosis	8.13e-05	0.00061	CcSEcCtD
Aprepitant—Pruritus—Ibandronate—osteoporosis	8.12e-05	0.000609	CcSEcCtD
Aprepitant—Pain—Risedronate—osteoporosis	8.09e-05	0.000606	CcSEcCtD
Aprepitant—Constipation—Risedronate—osteoporosis	8.09e-05	0.000606	CcSEcCtD
Aprepitant—Angiopathy—Estradiol—osteoporosis	8.08e-05	0.000606	CcSEcCtD
Aprepitant—Shock—Zoledronate—osteoporosis	8.08e-05	0.000606	CcSEcCtD
Aprepitant—Paraesthesia—Pamidronate—osteoporosis	8.07e-05	0.000605	CcSEcCtD
Aprepitant—Diarrhoea—Alendronate—osteoporosis	8.07e-05	0.000605	CcSEcCtD
Aprepitant—Asthenia—Calcitriol—osteoporosis	8.06e-05	0.000604	CcSEcCtD
Aprepitant—Nervous system disorder—Zoledronate—osteoporosis	8.05e-05	0.000604	CcSEcCtD
Aprepitant—Immune system disorder—Estradiol—osteoporosis	8.05e-05	0.000603	CcSEcCtD
Aprepitant—Thrombocytopenia—Zoledronate—osteoporosis	8.04e-05	0.000603	CcSEcCtD
Aprepitant—Mediastinal disorder—Estradiol—osteoporosis	8.03e-05	0.000602	CcSEcCtD
Aprepitant—Dyspnoea—Pamidronate—osteoporosis	8.02e-05	0.000601	CcSEcCtD
Aprepitant—Tachycardia—Zoledronate—osteoporosis	8.02e-05	0.000601	CcSEcCtD
Aprepitant—Feeling abnormal—Ethinyl Estradiol—osteoporosis	7.99e-05	0.000599	CcSEcCtD
Aprepitant—Chills—Estradiol—osteoporosis	7.99e-05	0.000599	CcSEcCtD
Aprepitant—Somnolence—Pamidronate—osteoporosis	7.99e-05	0.000599	CcSEcCtD
Aprepitant—Skin disorder—Zoledronate—osteoporosis	7.98e-05	0.000598	CcSEcCtD
Aprepitant—Pruritus—Calcitriol—osteoporosis	7.95e-05	0.000596	CcSEcCtD
Aprepitant—Hyperhidrosis—Zoledronate—osteoporosis	7.94e-05	0.000595	CcSEcCtD
Aprepitant—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	7.93e-05	0.000595	CcSEcCtD
Aprepitant—Diarrhoea—Raloxifene—osteoporosis	7.93e-05	0.000595	CcSEcCtD
Aprepitant—Dyspepsia—Pamidronate—osteoporosis	7.91e-05	0.000593	CcSEcCtD
Aprepitant—Dizziness—Estropipate—osteoporosis	7.91e-05	0.000593	CcSEcCtD
Aprepitant—Anaphylactic shock—Conjugated Estrogens—osteoporosis	7.91e-05	0.000593	CcSEcCtD
Aprepitant—Oedema—Conjugated Estrogens—osteoporosis	7.91e-05	0.000593	CcSEcCtD
Aprepitant—Alopecia—Estradiol—osteoporosis	7.87e-05	0.00059	CcSEcCtD
Aprepitant—Infection—Conjugated Estrogens—osteoporosis	7.86e-05	0.000589	CcSEcCtD
Aprepitant—Diarrhoea—Ibandronate—osteoporosis	7.85e-05	0.000589	CcSEcCtD
Aprepitant—Anorexia—Zoledronate—osteoporosis	7.83e-05	0.000587	CcSEcCtD
Aprepitant—Decreased appetite—Pamidronate—osteoporosis	7.82e-05	0.000586	CcSEcCtD
Aprepitant—Mental disorder—Estradiol—osteoporosis	7.8e-05	0.000585	CcSEcCtD
Aprepitant—Dizziness—Alendronate—osteoporosis	7.79e-05	0.000584	CcSEcCtD
Aprepitant—Shock—Conjugated Estrogens—osteoporosis	7.78e-05	0.000583	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Pamidronate—osteoporosis	7.76e-05	0.000582	CcSEcCtD
Aprepitant—Nervous system disorder—Conjugated Estrogens—osteoporosis	7.75e-05	0.000581	CcSEcCtD
Aprepitant—Erythema—Estradiol—osteoporosis	7.75e-05	0.000581	CcSEcCtD
Aprepitant—Malnutrition—Estradiol—osteoporosis	7.75e-05	0.000581	CcSEcCtD
Aprepitant—Fatigue—Pamidronate—osteoporosis	7.75e-05	0.000581	CcSEcCtD
Aprepitant—Gastrointestinal pain—Risedronate—osteoporosis	7.73e-05	0.00058	CcSEcCtD
Aprepitant—Tachycardia—Conjugated Estrogens—osteoporosis	7.72e-05	0.000579	CcSEcCtD
Aprepitant—Urticaria—Ethinyl Estradiol—osteoporosis	7.71e-05	0.000578	CcSEcCtD
Aprepitant—Pain—Pamidronate—osteoporosis	7.69e-05	0.000576	CcSEcCtD
Aprepitant—Constipation—Pamidronate—osteoporosis	7.69e-05	0.000576	CcSEcCtD
Aprepitant—Diarrhoea—Calcitriol—osteoporosis	7.69e-05	0.000576	CcSEcCtD
Aprepitant—Skin disorder—Conjugated Estrogens—osteoporosis	7.68e-05	0.000576	CcSEcCtD
Aprepitant—Hypotension—Zoledronate—osteoporosis	7.67e-05	0.000575	CcSEcCtD
Aprepitant—Body temperature increased—Ethinyl Estradiol—osteoporosis	7.67e-05	0.000575	CcSEcCtD
Aprepitant—Abdominal pain—Ethinyl Estradiol—osteoporosis	7.67e-05	0.000575	CcSEcCtD
Aprepitant—Dizziness—Raloxifene—osteoporosis	7.67e-05	0.000575	CcSEcCtD
Aprepitant—Hyperhidrosis—Conjugated Estrogens—osteoporosis	7.64e-05	0.000573	CcSEcCtD
Aprepitant—Flatulence—Estradiol—osteoporosis	7.64e-05	0.000573	CcSEcCtD
Aprepitant—Vomiting—Estropipate—osteoporosis	7.61e-05	0.00057	CcSEcCtD
Aprepitant—Dysgeusia—Estradiol—osteoporosis	7.59e-05	0.000569	CcSEcCtD
Aprepitant—Dizziness—Ibandronate—osteoporosis	7.59e-05	0.000569	CcSEcCtD
Aprepitant—Rash—Estropipate—osteoporosis	7.55e-05	0.000566	CcSEcCtD
Aprepitant—Dermatitis—Estropipate—osteoporosis	7.54e-05	0.000565	CcSEcCtD
Aprepitant—Anorexia—Conjugated Estrogens—osteoporosis	7.54e-05	0.000565	CcSEcCtD
Aprepitant—Urticaria—Risedronate—osteoporosis	7.51e-05	0.000563	CcSEcCtD
Aprepitant—Back pain—Estradiol—osteoporosis	7.5e-05	0.000562	CcSEcCtD
Aprepitant—Headache—Estropipate—osteoporosis	7.5e-05	0.000562	CcSEcCtD
Aprepitant—Vomiting—Alendronate—osteoporosis	7.49e-05	0.000562	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Zoledronate—osteoporosis	7.48e-05	0.000561	CcSEcCtD
Aprepitant—Abdominal pain—Risedronate—osteoporosis	7.48e-05	0.000561	CcSEcCtD
Aprepitant—Body temperature increased—Risedronate—osteoporosis	7.48e-05	0.000561	CcSEcCtD
Aprepitant—Muscle spasms—Estradiol—osteoporosis	7.46e-05	0.000559	CcSEcCtD
Aprepitant—Rash—Alendronate—osteoporosis	7.43e-05	0.000557	CcSEcCtD
Aprepitant—Insomnia—Zoledronate—osteoporosis	7.43e-05	0.000557	CcSEcCtD
Aprepitant—Dermatitis—Alendronate—osteoporosis	7.43e-05	0.000557	CcSEcCtD
Aprepitant—Feeling abnormal—Pamidronate—osteoporosis	7.41e-05	0.000555	CcSEcCtD
Aprepitant—Hypotension—Conjugated Estrogens—osteoporosis	7.39e-05	0.000554	CcSEcCtD
Aprepitant—Headache—Alendronate—osteoporosis	7.38e-05	0.000554	CcSEcCtD
Aprepitant—Paraesthesia—Zoledronate—osteoporosis	7.37e-05	0.000553	CcSEcCtD
Aprepitant—Vomiting—Raloxifene—osteoporosis	7.37e-05	0.000553	CcSEcCtD
Aprepitant—Gastrointestinal pain—Pamidronate—osteoporosis	7.35e-05	0.000551	CcSEcCtD
Aprepitant—Dyspnoea—Zoledronate—osteoporosis	7.32e-05	0.000549	CcSEcCtD
Aprepitant—Rash—Raloxifene—osteoporosis	7.31e-05	0.000548	CcSEcCtD
Aprepitant—Dermatitis—Raloxifene—osteoporosis	7.3e-05	0.000547	CcSEcCtD
Aprepitant—Somnolence—Zoledronate—osteoporosis	7.3e-05	0.000547	CcSEcCtD
Aprepitant—Vomiting—Ibandronate—osteoporosis	7.3e-05	0.000547	CcSEcCtD
Aprepitant—Tremor—Estradiol—osteoporosis	7.27e-05	0.000545	CcSEcCtD
Aprepitant—Headache—Raloxifene—osteoporosis	7.26e-05	0.000544	CcSEcCtD
Aprepitant—Rash—Ibandronate—osteoporosis	7.24e-05	0.000542	CcSEcCtD
Aprepitant—Dermatitis—Ibandronate—osteoporosis	7.23e-05	0.000542	CcSEcCtD
Aprepitant—Dyspepsia—Zoledronate—osteoporosis	7.23e-05	0.000542	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	7.2e-05	0.00054	CcSEcCtD
Aprepitant—Ill-defined disorder—Estradiol—osteoporosis	7.2e-05	0.000539	CcSEcCtD
Aprepitant—Headache—Ibandronate—osteoporosis	7.19e-05	0.000539	CcSEcCtD
Aprepitant—Insomnia—Conjugated Estrogens—osteoporosis	7.15e-05	0.000536	CcSEcCtD
Aprepitant—Hypersensitivity—Ethinyl Estradiol—osteoporosis	7.15e-05	0.000536	CcSEcCtD
Aprepitant—Vomiting—Calcitriol—osteoporosis	7.14e-05	0.000536	CcSEcCtD
Aprepitant—Decreased appetite—Zoledronate—osteoporosis	7.14e-05	0.000535	CcSEcCtD
Aprepitant—Nausea—Estropipate—osteoporosis	7.11e-05	0.000533	CcSEcCtD
Aprepitant—Abdominal pain—Pamidronate—osteoporosis	7.11e-05	0.000533	CcSEcCtD
Aprepitant—Body temperature increased—Pamidronate—osteoporosis	7.11e-05	0.000533	CcSEcCtD
Aprepitant—Paraesthesia—Conjugated Estrogens—osteoporosis	7.1e-05	0.000532	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Zoledronate—osteoporosis	7.09e-05	0.000532	CcSEcCtD
Aprepitant—Angioedema—Estradiol—osteoporosis	7.09e-05	0.000531	CcSEcCtD
Aprepitant—Rash—Calcitriol—osteoporosis	7.08e-05	0.000531	CcSEcCtD
Aprepitant—Fatigue—Zoledronate—osteoporosis	7.08e-05	0.000531	CcSEcCtD
Aprepitant—Dermatitis—Calcitriol—osteoporosis	7.08e-05	0.000531	CcSEcCtD
Aprepitant—Dyspnoea—Conjugated Estrogens—osteoporosis	7.05e-05	0.000529	CcSEcCtD
Aprepitant—Headache—Calcitriol—osteoporosis	7.04e-05	0.000528	CcSEcCtD
Aprepitant—Somnolence—Conjugated Estrogens—osteoporosis	7.03e-05	0.000527	CcSEcCtD
Aprepitant—Constipation—Zoledronate—osteoporosis	7.02e-05	0.000527	CcSEcCtD
Aprepitant—Pain—Zoledronate—osteoporosis	7.02e-05	0.000527	CcSEcCtD
Aprepitant—Nausea—Alendronate—osteoporosis	7e-05	0.000525	CcSEcCtD
Aprepitant—Malaise—Estradiol—osteoporosis	6.99e-05	0.000524	CcSEcCtD
Aprepitant—Hypersensitivity—Risedronate—osteoporosis	6.97e-05	0.000522	CcSEcCtD
Aprepitant—Dyspepsia—Conjugated Estrogens—osteoporosis	6.96e-05	0.000522	CcSEcCtD
Aprepitant—Asthenia—Ethinyl Estradiol—osteoporosis	6.96e-05	0.000522	CcSEcCtD
Aprepitant—Syncope—Estradiol—osteoporosis	6.95e-05	0.000521	CcSEcCtD
Aprepitant—Nausea—Raloxifene—osteoporosis	6.89e-05	0.000516	CcSEcCtD
Aprepitant—Decreased appetite—Conjugated Estrogens—osteoporosis	6.87e-05	0.000515	CcSEcCtD
Aprepitant—Pruritus—Ethinyl Estradiol—osteoporosis	6.86e-05	0.000515	CcSEcCtD
Aprepitant—Palpitations—Estradiol—osteoporosis	6.85e-05	0.000514	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	6.83e-05	0.000512	CcSEcCtD
Aprepitant—Fatigue—Conjugated Estrogens—osteoporosis	6.82e-05	0.000511	CcSEcCtD
Aprepitant—Nausea—Ibandronate—osteoporosis	6.82e-05	0.000511	CcSEcCtD
Aprepitant—Loss of consciousness—Estradiol—osteoporosis	6.82e-05	0.000511	CcSEcCtD
Aprepitant—Asthenia—Risedronate—osteoporosis	6.79e-05	0.000509	CcSEcCtD
Aprepitant—Feeling abnormal—Zoledronate—osteoporosis	6.77e-05	0.000507	CcSEcCtD
Aprepitant—Cough—Estradiol—osteoporosis	6.77e-05	0.000507	CcSEcCtD
Aprepitant—Constipation—Conjugated Estrogens—osteoporosis	6.76e-05	0.000507	CcSEcCtD
Aprepitant—Pain—Conjugated Estrogens—osteoporosis	6.76e-05	0.000507	CcSEcCtD
Aprepitant—Gastrointestinal pain—Zoledronate—osteoporosis	6.72e-05	0.000503	CcSEcCtD
Aprepitant—Hypertension—Estradiol—osteoporosis	6.7e-05	0.000502	CcSEcCtD
Aprepitant—Pruritus—Risedronate—osteoporosis	6.69e-05	0.000502	CcSEcCtD
Aprepitant—Nausea—Calcitriol—osteoporosis	6.67e-05	0.0005	CcSEcCtD
Aprepitant—Diarrhoea—Ethinyl Estradiol—osteoporosis	6.64e-05	0.000498	CcSEcCtD
Aprepitant—Hypersensitivity—Pamidronate—osteoporosis	6.62e-05	0.000497	CcSEcCtD
Aprepitant—Myalgia—Estradiol—osteoporosis	6.6e-05	0.000495	CcSEcCtD
Aprepitant—Chest pain—Estradiol—osteoporosis	6.6e-05	0.000495	CcSEcCtD
Aprepitant—Arthralgia—Estradiol—osteoporosis	6.6e-05	0.000495	CcSEcCtD
Aprepitant—Anxiety—Estradiol—osteoporosis	6.58e-05	0.000493	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	6.56e-05	0.000492	CcSEcCtD
Aprepitant—Urticaria—Zoledronate—osteoporosis	6.52e-05	0.000489	CcSEcCtD
Aprepitant—Discomfort—Estradiol—osteoporosis	6.52e-05	0.000489	CcSEcCtD
Aprepitant—Body temperature increased—Zoledronate—osteoporosis	6.49e-05	0.000487	CcSEcCtD
Aprepitant—Abdominal pain—Zoledronate—osteoporosis	6.49e-05	0.000487	CcSEcCtD
Aprepitant—Diarrhoea—Risedronate—osteoporosis	6.47e-05	0.000485	CcSEcCtD
Aprepitant—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	6.47e-05	0.000485	CcSEcCtD
Aprepitant—Dry mouth—Estradiol—osteoporosis	6.46e-05	0.000484	CcSEcCtD
Aprepitant—Asthenia—Pamidronate—osteoporosis	6.45e-05	0.000484	CcSEcCtD
Aprepitant—Dizziness—Ethinyl Estradiol—osteoporosis	6.41e-05	0.000481	CcSEcCtD
Aprepitant—Confusional state—Estradiol—osteoporosis	6.38e-05	0.000478	CcSEcCtD
Aprepitant—Pruritus—Pamidronate—osteoporosis	6.36e-05	0.000477	CcSEcCtD
Aprepitant—Oedema—Estradiol—osteoporosis	6.33e-05	0.000474	CcSEcCtD
Aprepitant—Anaphylactic shock—Estradiol—osteoporosis	6.33e-05	0.000474	CcSEcCtD
Aprepitant—Infection—Estradiol—osteoporosis	6.29e-05	0.000471	CcSEcCtD
Aprepitant—Urticaria—Conjugated Estrogens—osteoporosis	6.28e-05	0.000471	CcSEcCtD
Aprepitant—Dizziness—Risedronate—osteoporosis	6.25e-05	0.000469	CcSEcCtD
Aprepitant—Abdominal pain—Conjugated Estrogens—osteoporosis	6.25e-05	0.000469	CcSEcCtD
Aprepitant—Body temperature increased—Conjugated Estrogens—osteoporosis	6.25e-05	0.000469	CcSEcCtD
Aprepitant—Shock—Estradiol—osteoporosis	6.23e-05	0.000467	CcSEcCtD
Aprepitant—Nervous system disorder—Estradiol—osteoporosis	6.21e-05	0.000465	CcSEcCtD
Aprepitant—Tachycardia—Estradiol—osteoporosis	6.18e-05	0.000463	CcSEcCtD
Aprepitant—Vomiting—Ethinyl Estradiol—osteoporosis	6.17e-05	0.000462	CcSEcCtD
Aprepitant—Diarrhoea—Pamidronate—osteoporosis	6.15e-05	0.000461	CcSEcCtD
Aprepitant—Skin disorder—Estradiol—osteoporosis	6.15e-05	0.000461	CcSEcCtD
Aprepitant—Hyperhidrosis—Estradiol—osteoporosis	6.12e-05	0.000459	CcSEcCtD
Aprepitant—Rash—Ethinyl Estradiol—osteoporosis	6.12e-05	0.000459	CcSEcCtD
Aprepitant—Dermatitis—Ethinyl Estradiol—osteoporosis	6.11e-05	0.000458	CcSEcCtD
Aprepitant—Headache—Ethinyl Estradiol—osteoporosis	6.08e-05	0.000456	CcSEcCtD
Aprepitant—Hypersensitivity—Zoledronate—osteoporosis	6.05e-05	0.000454	CcSEcCtD
Aprepitant—Vomiting—Risedronate—osteoporosis	6.01e-05	0.000451	CcSEcCtD
Aprepitant—Rash—Risedronate—osteoporosis	5.96e-05	0.000447	CcSEcCtD
Aprepitant—Dermatitis—Risedronate—osteoporosis	5.96e-05	0.000447	CcSEcCtD
Aprepitant—Dizziness—Pamidronate—osteoporosis	5.95e-05	0.000446	CcSEcCtD
Aprepitant—Headache—Risedronate—osteoporosis	5.93e-05	0.000444	CcSEcCtD
Aprepitant—Asthenia—Zoledronate—osteoporosis	5.89e-05	0.000442	CcSEcCtD
Aprepitant—Hypersensitivity—Conjugated Estrogens—osteoporosis	5.83e-05	0.000437	CcSEcCtD
Aprepitant—Pruritus—Zoledronate—osteoporosis	5.81e-05	0.000436	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Estradiol—osteoporosis	5.77e-05	0.000432	CcSEcCtD
Aprepitant—Nausea—Ethinyl Estradiol—osteoporosis	5.76e-05	0.000432	CcSEcCtD
Aprepitant—Insomnia—Estradiol—osteoporosis	5.72e-05	0.000429	CcSEcCtD
Aprepitant—Vomiting—Pamidronate—osteoporosis	5.72e-05	0.000429	CcSEcCtD
Aprepitant—Paraesthesia—Estradiol—osteoporosis	5.68e-05	0.000426	CcSEcCtD
Aprepitant—Asthenia—Conjugated Estrogens—osteoporosis	5.67e-05	0.000425	CcSEcCtD
Aprepitant—Rash—Pamidronate—osteoporosis	5.67e-05	0.000425	CcSEcCtD
Aprepitant—Dermatitis—Pamidronate—osteoporosis	5.66e-05	0.000425	CcSEcCtD
Aprepitant—Dyspnoea—Estradiol—osteoporosis	5.64e-05	0.000423	CcSEcCtD
Aprepitant—Headache—Pamidronate—osteoporosis	5.63e-05	0.000422	CcSEcCtD
Aprepitant—Somnolence—Estradiol—osteoporosis	5.63e-05	0.000422	CcSEcCtD
Aprepitant—Diarrhoea—Zoledronate—osteoporosis	5.62e-05	0.000421	CcSEcCtD
Aprepitant—Nausea—Risedronate—osteoporosis	5.62e-05	0.000421	CcSEcCtD
Aprepitant—Pruritus—Conjugated Estrogens—osteoporosis	5.59e-05	0.000419	CcSEcCtD
Aprepitant—Dyspepsia—Estradiol—osteoporosis	5.57e-05	0.000418	CcSEcCtD
Aprepitant—Decreased appetite—Estradiol—osteoporosis	5.5e-05	0.000412	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Estradiol—osteoporosis	5.46e-05	0.00041	CcSEcCtD
Aprepitant—Fatigue—Estradiol—osteoporosis	5.46e-05	0.000409	CcSEcCtD
Aprepitant—Dizziness—Zoledronate—osteoporosis	5.43e-05	0.000407	CcSEcCtD
Aprepitant—Pain—Estradiol—osteoporosis	5.41e-05	0.000406	CcSEcCtD
Aprepitant—Constipation—Estradiol—osteoporosis	5.41e-05	0.000406	CcSEcCtD
Aprepitant—Diarrhoea—Conjugated Estrogens—osteoporosis	5.41e-05	0.000406	CcSEcCtD
Aprepitant—Nausea—Pamidronate—osteoporosis	5.34e-05	0.0004	CcSEcCtD
Aprepitant—Dizziness—Conjugated Estrogens—osteoporosis	5.23e-05	0.000392	CcSEcCtD
Aprepitant—Vomiting—Zoledronate—osteoporosis	5.22e-05	0.000391	CcSEcCtD
Aprepitant—Feeling abnormal—Estradiol—osteoporosis	5.22e-05	0.000391	CcSEcCtD
Aprepitant—Rash—Zoledronate—osteoporosis	5.18e-05	0.000388	CcSEcCtD
Aprepitant—Gastrointestinal pain—Estradiol—osteoporosis	5.18e-05	0.000388	CcSEcCtD
Aprepitant—Dermatitis—Zoledronate—osteoporosis	5.17e-05	0.000388	CcSEcCtD
Aprepitant—Headache—Zoledronate—osteoporosis	5.14e-05	0.000386	CcSEcCtD
Aprepitant—Vomiting—Conjugated Estrogens—osteoporosis	5.03e-05	0.000377	CcSEcCtD
Aprepitant—Urticaria—Estradiol—osteoporosis	5.03e-05	0.000377	CcSEcCtD
Aprepitant—Abdominal pain—Estradiol—osteoporosis	5e-05	0.000375	CcSEcCtD
Aprepitant—Body temperature increased—Estradiol—osteoporosis	5e-05	0.000375	CcSEcCtD
Aprepitant—Rash—Conjugated Estrogens—osteoporosis	4.99e-05	0.000374	CcSEcCtD
Aprepitant—Dermatitis—Conjugated Estrogens—osteoporosis	4.98e-05	0.000373	CcSEcCtD
Aprepitant—Headache—Conjugated Estrogens—osteoporosis	4.95e-05	0.000371	CcSEcCtD
Aprepitant—Nausea—Zoledronate—osteoporosis	4.88e-05	0.000366	CcSEcCtD
Aprepitant—Nausea—Conjugated Estrogens—osteoporosis	4.7e-05	0.000352	CcSEcCtD
Aprepitant—Hypersensitivity—Estradiol—osteoporosis	4.66e-05	0.00035	CcSEcCtD
Aprepitant—Asthenia—Estradiol—osteoporosis	4.54e-05	0.00034	CcSEcCtD
Aprepitant—Pruritus—Estradiol—osteoporosis	4.48e-05	0.000336	CcSEcCtD
Aprepitant—Diarrhoea—Estradiol—osteoporosis	4.33e-05	0.000325	CcSEcCtD
Aprepitant—Dizziness—Estradiol—osteoporosis	4.19e-05	0.000314	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—TLN1—osteoporosis	4.06e-05	0.00175	CbGpPWpGaD
Aprepitant—Vomiting—Estradiol—osteoporosis	4.02e-05	0.000302	CcSEcCtD
Aprepitant—Rash—Estradiol—osteoporosis	3.99e-05	0.000299	CcSEcCtD
Aprepitant—Dermatitis—Estradiol—osteoporosis	3.99e-05	0.000299	CcSEcCtD
Aprepitant—Headache—Estradiol—osteoporosis	3.96e-05	0.000297	CcSEcCtD
Aprepitant—CYP3A5—Biological oxidations—CYP19A1—osteoporosis	3.93e-05	0.00169	CbGpPWpGaD
Aprepitant—CYP3A5—Metapathway biotransformation—CYP19A1—osteoporosis	3.88e-05	0.00167	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	3.87e-05	0.00166	CbGpPWpGaD
Aprepitant—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.87e-05	0.00166	CbGpPWpGaD
Aprepitant—Nausea—Estradiol—osteoporosis	3.76e-05	0.000282	CcSEcCtD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3.67e-05	0.00158	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—ADCY5—osteoporosis	3.62e-05	0.00156	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	3.53e-05	0.00152	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—P4HB—osteoporosis	3.51e-05	0.00151	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—SPP1—osteoporosis	3.51e-05	0.00151	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	3.48e-05	0.0015	CbGpPWpGaD
Aprepitant—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	3.44e-05	0.00148	CbGpPWpGaD
Aprepitant—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.44e-05	0.00148	CbGpPWpGaD
Aprepitant—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	3.43e-05	0.00148	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PTH—osteoporosis	3.41e-05	0.00147	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—RAP1A—osteoporosis	3.35e-05	0.00144	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3.34e-05	0.00144	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CNR2—osteoporosis	3.32e-05	0.00143	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	3.31e-05	0.00142	CbGpPWpGaD
Aprepitant—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.3e-05	0.00142	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—ADCY5—osteoporosis	3.3e-05	0.00142	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NFATC1—osteoporosis	3.27e-05	0.00141	CbGpPWpGaD
Aprepitant—CYP3A7—Biological oxidations—POMC—osteoporosis	3.27e-05	0.00141	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—DKK1—osteoporosis	3.24e-05	0.00139	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IRS2—osteoporosis	3.17e-05	0.00136	CbGpPWpGaD
Aprepitant—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.13e-05	0.00135	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—WNT1—osteoporosis	3.12e-05	0.00134	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—LEP—osteoporosis	3.1e-05	0.00133	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—FDPS—osteoporosis	3.08e-05	0.00133	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PKM—osteoporosis	3.08e-05	0.00133	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—FGA—osteoporosis	3.04e-05	0.00131	CbGpPWpGaD
Aprepitant—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	3.04e-05	0.00131	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	3.03e-05	0.0013	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	3.01e-05	0.0013	CbGpPWpGaD
Aprepitant—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	3e-05	0.00129	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—ADCY5—osteoporosis	3e-05	0.00129	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—ESR1—osteoporosis	2.96e-05	0.00127	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PGLS—osteoporosis	2.92e-05	0.00126	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GPD2—osteoporosis	2.92e-05	0.00126	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	2.86e-05	0.00123	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.85e-05	0.00123	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PTHLH—osteoporosis	2.83e-05	0.00122	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—BMP2—osteoporosis	2.83e-05	0.00122	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.78e-05	0.00119	CbGpPWpGaD
Aprepitant—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	2.77e-05	0.00119	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IRS1—osteoporosis	2.77e-05	0.00119	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—FGB—osteoporosis	2.76e-05	0.00119	CbGpPWpGaD
Aprepitant—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	2.73e-05	0.00118	CbGpPWpGaD
Aprepitant—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.68e-05	0.00115	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ATIC—osteoporosis	2.67e-05	0.00115	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PNP—osteoporosis	2.67e-05	0.00115	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PSMA5—osteoporosis	2.67e-05	0.00115	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PSMA2—osteoporosis	2.67e-05	0.00115	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—POMC—osteoporosis	2.66e-05	0.00115	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL6R—osteoporosis	2.6e-05	0.00112	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.6e-05	0.00112	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IGF1—osteoporosis	2.56e-05	0.0011	CbGpPWpGaD
Aprepitant—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.55e-05	0.0011	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.53e-05	0.00109	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CALCA—osteoporosis	2.49e-05	0.00107	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—POMC—osteoporosis	2.43e-05	0.00104	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	2.37e-05	0.00102	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	2.36e-05	0.00102	CbGpPWpGaD
Aprepitant—CYP3A5—Biological oxidations—POMC—osteoporosis	2.36e-05	0.00102	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	2.36e-05	0.00101	CbGpPWpGaD
Aprepitant—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	2.33e-05	0.001	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CA2—osteoporosis	2.27e-05	0.000977	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—OXCT1—osteoporosis	2.27e-05	0.000977	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—KL—osteoporosis	2.26e-05	0.000971	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PKM—osteoporosis	2.23e-05	0.000958	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—FDPS—osteoporosis	2.23e-05	0.000958	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.22e-05	0.000955	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.22e-05	0.000955	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—MGLL—osteoporosis	2.21e-05	0.000952	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—POMC—osteoporosis	2.2e-05	0.000947	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	2.2e-05	0.000946	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	2.2e-05	0.000946	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.16e-05	0.000931	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL6R—osteoporosis	2.15e-05	0.000924	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GPD2—osteoporosis	2.11e-05	0.000908	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PGLS—osteoporosis	2.11e-05	0.000908	CbGpPWpGaD
Aprepitant—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.07e-05	0.000889	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.03e-05	0.000871	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—IL6—osteoporosis	1.96e-05	0.000843	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PNP—osteoporosis	1.93e-05	0.000831	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ATIC—osteoporosis	1.93e-05	0.000831	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.89e-05	0.000812	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—IDH2—osteoporosis	1.88e-05	0.00081	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.83e-05	0.000786	CbGpPWpGaD
Aprepitant—CYP2C19—Biological oxidations—POMC—osteoporosis	1.83e-05	0.000785	CbGpPWpGaD
Aprepitant—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.8e-05	0.000775	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP27A1—osteoporosis	1.77e-05	0.000761	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—ADCY5—osteoporosis	1.77e-05	0.000761	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.73e-05	0.000744	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PKM—osteoporosis	1.72e-05	0.000741	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—FDPS—osteoporosis	1.72e-05	0.000741	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.72e-05	0.000741	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ACP5—osteoporosis	1.72e-05	0.00074	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SPP1—osteoporosis	1.71e-05	0.000736	CbGpPWpGaD
Aprepitant—CYP2C9—Biological oxidations—POMC—osteoporosis	1.66e-05	0.000716	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CA2—osteoporosis	1.64e-05	0.000706	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—OXCT1—osteoporosis	1.64e-05	0.000706	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PGLS—osteoporosis	1.63e-05	0.000702	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GPD2—osteoporosis	1.63e-05	0.000702	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—TPI1—osteoporosis	1.6e-05	0.000688	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—MGLL—osteoporosis	1.6e-05	0.000688	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—FDPS—osteoporosis	1.57e-05	0.000675	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PKM—osteoporosis	1.57e-05	0.000675	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IRS2—osteoporosis	1.55e-05	0.000666	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—MYC—osteoporosis	1.54e-05	0.000663	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TGFB1—osteoporosis	1.54e-05	0.000661	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—LEP—osteoporosis	1.51e-05	0.000652	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—P4HB—osteoporosis	1.5e-05	0.000647	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PNP—osteoporosis	1.49e-05	0.000642	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ATIC—osteoporosis	1.49e-05	0.000642	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PGLS—osteoporosis	1.49e-05	0.00064	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GPD2—osteoporosis	1.49e-05	0.00064	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GAPDH—osteoporosis	1.48e-05	0.000635	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.47e-05	0.000633	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—ESR1—osteoporosis	1.45e-05	0.000622	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—RAP1A—osteoporosis	1.44e-05	0.000619	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—POMC—osteoporosis	1.42e-05	0.000612	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PNP—osteoporosis	1.36e-05	0.000586	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ATIC—osteoporosis	1.36e-05	0.000586	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—IDH2—osteoporosis	1.36e-05	0.000585	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IRS1—osteoporosis	1.35e-05	0.000581	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PKM—osteoporosis	1.34e-05	0.000577	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—FDPS—osteoporosis	1.34e-05	0.000577	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—POMC—osteoporosis	1.3e-05	0.00056	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP27A1—osteoporosis	1.28e-05	0.00055	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PGLS—osteoporosis	1.27e-05	0.000547	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GPD2—osteoporosis	1.27e-05	0.000547	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—OXCT1—osteoporosis	1.27e-05	0.000546	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CA2—osteoporosis	1.27e-05	0.000546	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL6R—osteoporosis	1.27e-05	0.000546	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IGF1—osteoporosis	1.25e-05	0.000538	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ACP5—osteoporosis	1.24e-05	0.000535	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—MGLL—osteoporosis	1.24e-05	0.000532	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.17e-05	0.000502	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PNP—osteoporosis	1.16e-05	0.0005	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ATIC—osteoporosis	1.16e-05	0.0005	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ENO1—osteoporosis	1.16e-05	0.0005	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL6—osteoporosis	1.16e-05	0.000498	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—OXCT1—osteoporosis	1.16e-05	0.000498	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CA2—osteoporosis	1.16e-05	0.000498	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—TPI1—osteoporosis	1.16e-05	0.000498	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PSMA2—osteoporosis	1.15e-05	0.000493	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PSMA5—osteoporosis	1.15e-05	0.000493	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—MGLL—osteoporosis	1.13e-05	0.000485	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—POMC—osteoporosis	1.1e-05	0.000472	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—P4HB—osteoporosis	1.09e-05	0.000468	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GAPDH—osteoporosis	1.07e-05	0.000459	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.06e-05	0.000457	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—IDH2—osteoporosis	1.05e-05	0.000452	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—RAP1A—osteoporosis	1.04e-05	0.000447	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PKM—osteoporosis	1.04e-05	0.000445	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—FDPS—osteoporosis	1.04e-05	0.000445	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CA2—osteoporosis	9.89e-06	0.000425	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—OXCT1—osteoporosis	9.89e-06	0.000425	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP27A1—osteoporosis	9.89e-06	0.000425	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GPD2—osteoporosis	9.82e-06	0.000422	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PGLS—osteoporosis	9.82e-06	0.000422	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MGLL—osteoporosis	9.64e-06	0.000415	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ACP5—osteoporosis	9.62e-06	0.000414	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—IDH2—osteoporosis	9.59e-06	0.000413	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL6—osteoporosis	9.57e-06	0.000412	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	9.5e-06	0.000409	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP19A1—osteoporosis	9.3e-06	0.0004	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	9.09e-06	0.000391	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP27A1—osteoporosis	9.02e-06	0.000388	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ATIC—osteoporosis	8.98e-06	0.000386	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PNP—osteoporosis	8.98e-06	0.000386	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—TPI1—osteoporosis	8.95e-06	0.000385	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ACP5—osteoporosis	8.77e-06	0.000377	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.66e-06	0.000373	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—P4HB—osteoporosis	8.41e-06	0.000362	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ENO1—osteoporosis	8.41e-06	0.000362	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PSMA5—osteoporosis	8.28e-06	0.000356	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PSMA2—osteoporosis	8.28e-06	0.000356	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GAPDH—osteoporosis	8.26e-06	0.000355	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—IDH2—osteoporosis	8.2e-06	0.000353	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—TPI1—osteoporosis	8.16e-06	0.000351	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—RAP1A—osteoporosis	8.04e-06	0.000346	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP27A1—osteoporosis	7.71e-06	0.000331	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—P4HB—osteoporosis	7.67e-06	0.00033	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CA2—osteoporosis	7.63e-06	0.000328	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—OXCT1—osteoporosis	7.63e-06	0.000328	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ADCY5—osteoporosis	7.6e-06	0.000327	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GPX1—osteoporosis	7.57e-06	0.000326	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GAPDH—osteoporosis	7.53e-06	0.000324	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MYC—osteoporosis	7.52e-06	0.000324	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TGFB1—osteoporosis	7.5e-06	0.000323	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ACP5—osteoporosis	7.5e-06	0.000322	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MGLL—osteoporosis	7.44e-06	0.00032	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	7.4e-06	0.000318	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—RAP1A—osteoporosis	7.33e-06	0.000315	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.01e-06	0.000302	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—MTHFR—osteoporosis	6.99e-06	0.0003	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—TPI1—osteoporosis	6.97e-06	0.0003	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP19A1—osteoporosis	6.72e-06	0.000289	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—P4HB—osteoporosis	6.55e-06	0.000282	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ENO1—osteoporosis	6.5e-06	0.00028	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GAPDH—osteoporosis	6.43e-06	0.000277	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PSMA2—osteoporosis	6.4e-06	0.000275	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PSMA5—osteoporosis	6.4e-06	0.000275	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.39e-06	0.000275	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—IDH2—osteoporosis	6.33e-06	0.000272	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—RAP1A—osteoporosis	6.26e-06	0.000269	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP27A1—osteoporosis	5.95e-06	0.000256	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ENO1—osteoporosis	5.93e-06	0.000255	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PSMA5—osteoporosis	5.84e-06	0.000251	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PSMA2—osteoporosis	5.84e-06	0.000251	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ACP5—osteoporosis	5.79e-06	0.000249	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL6—osteoporosis	5.66e-06	0.000243	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—POMC—osteoporosis	5.59e-06	0.00024	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ADCY5—osteoporosis	5.49e-06	0.000236	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GPX1—osteoporosis	5.47e-06	0.000235	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.46e-06	0.000235	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—TPI1—osteoporosis	5.38e-06	0.000231	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP19A1—osteoporosis	5.2e-06	0.000223	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ENO1—osteoporosis	5.06e-06	0.000218	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—P4HB—osteoporosis	5.06e-06	0.000217	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—MTHFR—osteoporosis	5.05e-06	0.000217	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PSMA5—osteoporosis	4.99e-06	0.000215	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PSMA2—osteoporosis	4.99e-06	0.000215	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GAPDH—osteoporosis	4.96e-06	0.000213	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—RAP1A—osteoporosis	4.83e-06	0.000208	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP19A1—osteoporosis	4.74e-06	0.000204	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ADCY5—osteoporosis	4.25e-06	0.000183	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GPX1—osteoporosis	4.23e-06	0.000182	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP19A1—osteoporosis	4.05e-06	0.000174	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—POMC—osteoporosis	4.04e-06	0.000174	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ENO1—osteoporosis	3.91e-06	0.000168	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—MTHFR—osteoporosis	3.9e-06	0.000168	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ADCY5—osteoporosis	3.87e-06	0.000166	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GPX1—osteoporosis	3.86e-06	0.000166	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PSMA2—osteoporosis	3.85e-06	0.000166	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PSMA5—osteoporosis	3.85e-06	0.000166	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—MTHFR—osteoporosis	3.56e-06	0.000153	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ADCY5—osteoporosis	3.31e-06	0.000142	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GPX1—osteoporosis	3.3e-06	0.000142	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP19A1—osteoporosis	3.12e-06	0.000134	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—POMC—osteoporosis	3.12e-06	0.000134	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MTHFR—osteoporosis	3.04e-06	0.000131	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—POMC—osteoporosis	2.85e-06	0.000122	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ADCY5—osteoporosis	2.55e-06	0.00011	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GPX1—osteoporosis	2.54e-06	0.000109	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—POMC—osteoporosis	2.43e-06	0.000105	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MTHFR—osteoporosis	2.35e-06	0.000101	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—POMC—osteoporosis	1.88e-06	8.08e-05	CbGpPWpGaD
